HSCA Comments on DEA Proposed Aggregate Production Quotas for Schedule I and II Controlled Substances
On behalf of the Healthcare Supply Chain Association (HSCA), we appreciate the opportunity to provide comments on the U.S. Drug Enforcement Administration’s (DEA) proposed aggregate production quotas for Schedule I and II controlled substances.
HSCA represents the nation’s leading healthcare group purchasing organizations (GPOs), the sourcing and purchasing partners to virtually all of America’s 7,000+ hospitals, as well as the vast majority of the 68,000+ long-term care facilities, surgery centers, clinics, and other healthcare providers.
Related Posts
HSCA Announces Healthcare Cybersecurity Key Considerations
The Healthcare Supply Chain Association (HSCA) today announced the release of key...
HSCA Joins Leading Healthcare Organizations in Supporting the CREATES Act (S.974)
We, the undersigned, commend you for your leadership and commitment to reducing...
Comments of the Healthcare Supply Chain Association (HSCA) to FDA on Facilitating Competition and Innovation in the Biological Products Marketplace
On behalf of the Healthcare Supply Chain Association (HSCA), thank you for the...
HSCA Comments on DEA Proposed Aggregate Production Quotas for Schedule I and II Controlled Substances
On behalf of the Healthcare Supply Chain Association (HSCA), we appreciate the...